DD: APONTIS PHARMA AG: be executive GmbH, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 14.05.2024 / 11:07 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Name and legal form: be executive GmbH 2. Reason for the notification a) Position / status Person closely associated with: Title: First name: Bruno Last name(s): Wohlschlegel Position: Member of the managing body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name APONTIS PHARMA AG b) LEI 894500ETO1J6MR8PDF91  4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: DE000A3CMGM5 b) Nature of the transaction Acquisition c) Price(s) and volume(s) Price(s) Volume(s) 8.88 EUR 8880.00 EUR d) Aggregated information Price Aggregated volume 8.8800 EUR 8880.0000 EUR e) Date of the transaction 13/05/2024; UTC+2 f) Place of the transaction Name: Tradegate MIC: TGAT 14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	APONTIS PHARMA AG
	Alfred-Nobel-Str. 10
	40789 Monheim
	Germany
Internet:	https://apontis-pharma.de/

End of News	EQS News Service

91495  14.05.2024 CET/CEST